1. Home
  2. TBPH vs HFWA Comparison

TBPH vs HFWA Comparison

Compare TBPH & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • HFWA
  • Stock Information
  • Founded
  • TBPH 2013
  • HFWA 1927
  • Country
  • TBPH United States
  • HFWA United States
  • Employees
  • TBPH N/A
  • HFWA N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • HFWA Banks
  • Sector
  • TBPH Health Care
  • HFWA Finance
  • Exchange
  • TBPH Nasdaq
  • HFWA Nasdaq
  • Market Cap
  • TBPH 699.0M
  • HFWA 773.1M
  • IPO Year
  • TBPH N/A
  • HFWA N/A
  • Fundamental
  • Price
  • TBPH $14.75
  • HFWA $22.49
  • Analyst Decision
  • TBPH Strong Buy
  • HFWA Buy
  • Analyst Count
  • TBPH 4
  • HFWA 3
  • Target Price
  • TBPH $23.00
  • HFWA $29.33
  • AVG Volume (30 Days)
  • TBPH 284.3K
  • HFWA 160.7K
  • Earning Date
  • TBPH 11-10-2025
  • HFWA 10-23-2025
  • Dividend Yield
  • TBPH N/A
  • HFWA 4.29%
  • EPS Growth
  • TBPH N/A
  • HFWA 53.03
  • EPS
  • TBPH 0.26
  • HFWA 1.65
  • Revenue
  • TBPH $77,205,000.00
  • HFWA $232,877,000.00
  • Revenue This Year
  • TBPH $79.82
  • HFWA $22.09
  • Revenue Next Year
  • TBPH N/A
  • HFWA $20.56
  • P/E Ratio
  • TBPH $59.49
  • HFWA $13.56
  • Revenue Growth
  • TBPH 24.49
  • HFWA 14.16
  • 52 Week Low
  • TBPH $7.90
  • HFWA $19.84
  • 52 Week High
  • TBPH $15.34
  • HFWA $27.58
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 58.51
  • HFWA 41.61
  • Support Level
  • TBPH $14.11
  • HFWA $21.79
  • Resistance Level
  • TBPH $15.34
  • HFWA $23.53
  • Average True Range (ATR)
  • TBPH 0.42
  • HFWA 0.61
  • MACD
  • TBPH 0.06
  • HFWA -0.01
  • Stochastic Oscillator
  • TBPH 63.55
  • HFWA 36.91

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

Share on Social Networks: